119-s664

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 664 Introduced in Senate

    (IS) ]

<DOC>

119th CONGRESS
 1st Session
 S. 664

 To replace the National Institute of Allergy and Infectious Diseases 
 with 3 separate national research institutes.

_______________________________________________________________________

 IN THE SENATE OF THE UNITED STATES

 February 20, 2025

 Mr. Paul (for himself and Mr. Tuberville) introduced the following 
 bill; which was read twice and referred to the Committee on Health, 
 Education, Labor, and Pensions

_______________________________________________________________________

 A BILL

 To replace the National Institute of Allergy and Infectious Diseases 
 with 3 separate national research institutes.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

 This Act may be cited as the ``NIH Reform Act''.

SEC. 2. DIVISION OF NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS 
 DISEASES.

    (a) Organization of National Research Institutes.--

Section 401 of 
the Public Health Service Act (42 U.S.C. 281) is amended--

    (1) in subsection

    (b) --
        (A) in paragraph

    (6) , by striking ``Allergy and 
 Infectious Diseases'' and inserting ``Allergic 
 Diseases'';
        (B) by redesignating paragraph

    (25) as paragraph

    (27) ; and
            (C) by inserting after paragraph

    (24) the 
 following:
 ``

    (25) The National Institute of Infectious Diseases.
 ``

    (26) The National Institute of Immunologic Diseases.''; 
 and

    (2) in subsection
            (d) (1) , by striking ``27'' and inserting 
 ``29''.

    (b) Appointment of Directors.--

    (1) In general.--

Section 405

    (a)

    (1) of the Public Health 
 Service Act (42 U.S.C. 284

    (a)

    (1) ) is amended--
        (A) by inserting ``, the Director of the National 
 Institute of Allergic Diseases, the Director of the 
 National Institute of Infectious Diseases, and the 
 Director of the National Institute of Immunologic 
 Diseases'' after ``National Cancer Institute''; and
        (B) by inserting ``by and with the advice and 
 consent of the Senate,'' after ``the President,''.

    (2) Terms.--

Section 405

    (a) of the Public Health Service Act 
 (42 U.S.C. 284

    (a) ) is amended by adding at the end the 
 following:
 ``

    (4) Certain appointments by the president.--The 
 appointments by the President of the Director of the National 
 Institute of Allergic Diseases, the Director of the National 
 Institute of Infectious Diseases, and the Director of the 
 National Institute of Immunologic Diseases shall be for terms 
 of 5 years. Each such Director may be reappointed for not more 
 than 1 additional term, in accordance paragraph

    (1) .''.

    (3) Transition.--Effective on the date of enactment of this 
 Act, the position of Director of the National Institute of 
 Allergy and Infectious Diseases is terminated, and the National 
 Institute of Allergic Diseases, the National Institute of 
 Infectious Diseases, and the National Institute of Immunologic 
 Diseases shall be overseen by the Director of the National 
 Institutes of Health until such time as the directors of each 
 such national institutes is appointed pursuant to 

section 405

    (a)

    (1) of the Public Health Service Act (42 U.S.C. 
 284

    (a)

    (1) ), as amended by paragraph

    (1) .
            (c) Duties of the National Institutes.--

    (1) National institute of allergic diseases.--Subpart 6 of 
 part C of title IV of the Public Health Service Act (42 U.S.C. 
 285f et seq.) is amended--
        (A) in the subpart heading, by striking ``Allergy 
 and Infectious Diseases'' and inserting ``Allergic 
 Diseases''; and
        (B) in 

section 446--
            (i) by striking ``Allergy and Infectious 
 Diseases'' and inserting ``Allergic Diseases''; 
 and
            (ii) by striking ``allergic and immunologic 
 diseases and disorders and infectious diseases, 
 including tropical diseases'' and inserting 
 ``allergic diseases and disorders''.

    (2) National institute of infectious diseases.--
        (A) In general.--Part C of title IV of the Public 
 Health Service Act (42 U.S.C. 285 et seq.) is amended 
 by adding at the end the following:

 ``Subpart 21--National Institute of Infectious Diseases

``

SEC. 464Z-10. PURPOSE OF THE INSTITUTE.

 ``The general purpose of the National Institute of Infectious 
Diseases is the conduct and support of research, training, health 
information dissemination, and other programs with respect to 
infectious diseases, including tropical diseases.''.
        (B) Transfer of authorities.--Sections 447A and 
 447B of the Public Health Service Act (42 U.S.C. 285f-
 2; 285f-3) are--
            (i) redesignated as sections 464z-11 and 
 464z-12, respectively; and
            (ii) transferred to appear after 

section 464z-10 of such Act, as added by subparagraph
        (A) .
            (C) Orderly transition.--The Director of the 
 National Institutes of Health shall take such steps as 
 are necessary to provide for the orderly transition to 
 the authority of the National Institute of Infectious 
 Diseases established under 

section 464z-10 of the 
 Public Health Service Act, as added by subparagraph
        (A) , from any authority related to infectious diseases 
 of the National Institute of Allergy and Infectious 
 Diseases, as in effect on the day before the date of 
 enactment of this Act.

    (3) National institute of immunologic diseases.--
        (A) In general.--Part C of title IV of the Public 
 Health Service Act (42 U.S.C. 285 et seq.), as amended 
 by paragraph

    (2) , is further amended by adding at the 
 end the following:

 ``Subpart 22--National Institute of Immunologic Diseases

``

SEC. 464Z-15. PURPOSE OF THE INSTITUTE.

 ``The general purpose of the National Institute of Immunologic 
Diseases is the conduct and support of research, training, health 
information dissemination, and other programs with respect to 
immunologic diseases and disorders.''.
        (B) Transfer of authorities.--Sections 447 and 447C 
 of the Public Health Service Act (42 U.S.C. 285f-1; 
 285f-4) are--
            (i) redesignated as sections 464z-16 and 
 464z-17, respectively; and
            (ii) transferred to appear after 

section 464z-15 of such Act, as added by subparagraph
        (A) .
            (C) Orderly transition.--The Director of the 
 National Institutes of Health shall take such steps as 
 are necessary to provide for the orderly transition to 
 the authority of the National Institute of Immunologic 
 Diseases established under 

section 464z-15 of the 
 Public Health Service Act, as added by subparagraph
        (A) , from any authority related to immunologic diseases 
 and disorders of the National Institute of Allergy and 
 Infectious Diseases, as in effect on the day before the 
 date of enactment of this Act.
            (d) Conforming Amendments.--

    (1) Section 404B of the Public Health Service Act (42 
 U.S.C. 283d) is amended by striking ``National Institute for 
 Allergy and Infectious Diseases'' and inserting ``National 
 Institute for Infectious Diseases''.

    (2) Section 404I of the Public Health Service Act (42 
 U.S.C. 283k) is amended--
        (A) in subsection

    (a)

    (1) , by striking ``or the 
 Director of the National Institute for Allergy and 
 Infectious Diseases''; and
 (B by striking ``or the National Institute for 
 Allergy and Infectious Diseases'' each place it 
 appears.

    (3) Section 442A

    (a) of the Public Health Service Act (42 
 U.S.C. 285d-8

    (a) ) is amended by striking ``Allergy and 
 Infectious Diseases'' and inserting ``Immunologic Diseases''.

    (e) References in Law.--Any reference in any law (including a 
regulation), guidance, map, document, record, or other paper of the 
United States to the National Institute of Allergy and Infectious 
Diseases, including with respect to the Director of such Institute, 
shall be deemed to be a reference to, as applicable, the National 
Institute of Allergic Diseases, the National Institute of Infectious 
Diseases, or the National Institute of Immunologic Diseases, including 
with respect to the Directors of such Institutes.
 <all>